Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Hamilton

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|February 22, 2024
Selling NHS patient dataJessica Morley, Nicola Hamilton, Luciano Floridi
Journal of Anatomy|February 12, 2009
Effects of glutamate receptor activation on NG2-glia in the rat optic nerveNicola Hamilton, Paul S Hubbard, Arthur M Butt
Glia|July 21, 2006
Regulation of the astrocyte resting membrane potential by cyclic AMP and protein kinase ASally Bolton, Kirsty Greenwood, Nicola Hamilton, et al.
Glia|June 18, 2009
Axons and astrocytes release ATP and glutamate to evoke calcium signals in NG2-gliaNicola Hamilton, Steve Vayro, Rebekah Wigley, et al.
Glia|February 23, 2008
Mechanisms of ATP- and glutamate-mediated calcium signaling in white matter astrocytesNicola Hamilton, Steven Vayro, Frank Kirchhoff, et al.
Analytical Biochemistry|February 19, 2013
Generation of assays and antibodies to facilitate the study of human 5'-tyrosyl DNA phosphodiesteraseGraeme Thomson, Amanda Watson, Keith Caldecott, et al.
F1000Research|October 15, 2016
An assay to measure poly(ADP ribose) glycohydrolase (PARG) activity in cellsDominic I James, Stephen Durant, Kay Eckersley, et al.
Journal of Water and Health|September 24, 2004
Evaluation of a new water treatment for point-of-use household applications to remove microorganisms and arsenic from drinking waterPhilip F Souter, Graeme D Cruickshank, Melanie Z Tankerville, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2019
Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores - A cautionary disclosureBen Acton, Helen F Small, Kate M Smith, et al.
Breast Cancer Research : BCR|November 21, 2013
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumorsClifford Hudis, Charles Swanton, Yelena Y Janjigian, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|February 22, 2024
Selling NHS patient dataJessica Morley, Nicola Hamilton, Luciano Floridi
Journal of Anatomy|February 12, 2009
Effects of glutamate receptor activation on NG2-glia in the rat optic nerveNicola Hamilton, Paul S Hubbard, Arthur M Butt
Glia|July 21, 2006
Regulation of the astrocyte resting membrane potential by cyclic AMP and protein kinase ASally Bolton, Kirsty Greenwood, Nicola Hamilton, et al.
Glia|June 18, 2009
Axons and astrocytes release ATP and glutamate to evoke calcium signals in NG2-gliaNicola Hamilton, Steve Vayro, Rebekah Wigley, et al.
Glia|February 23, 2008
Mechanisms of ATP- and glutamate-mediated calcium signaling in white matter astrocytesNicola Hamilton, Steven Vayro, Frank Kirchhoff, et al.
Analytical Biochemistry|February 19, 2013
Generation of assays and antibodies to facilitate the study of human 5'-tyrosyl DNA phosphodiesteraseGraeme Thomson, Amanda Watson, Keith Caldecott, et al.
F1000Research|October 15, 2016
An assay to measure poly(ADP ribose) glycohydrolase (PARG) activity in cellsDominic I James, Stephen Durant, Kay Eckersley, et al.
Journal of Water and Health|September 24, 2004
Evaluation of a new water treatment for point-of-use household applications to remove microorganisms and arsenic from drinking waterPhilip F Souter, Graeme D Cruickshank, Melanie Z Tankerville, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2019
Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores - A cautionary disclosureBen Acton, Helen F Small, Kate M Smith, et al.
Breast Cancer Research : BCR|November 21, 2013
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumorsClifford Hudis, Charles Swanton, Yelena Y Janjigian, et al.
Pageof 2